Xin Chen

Person

Lexington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceuti...
- Patent number 12,157,737
- Issue date Dec 3, 2024
- Novartis AG
- Mallesh Bushaboina
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 12,122,761
- Issue date Oct 22, 2024
- Novartis AG
- Amy Calhoun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,820,778
- Issue date Nov 21, 2023
- Novartis AG
- Amy Calhoun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceuti...
- Patent number 11,708,366
- Issue date Jul 25, 2023
- Novartis AG
- Mallesh Bushaboina
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,548,865
- Issue date Jan 10, 2023
- Novartis AG
- Amy Calhoun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,485,742
- Issue date Nov 1, 2022
- Novartis AG
- Amy Calhoun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclic ether DGAT1 inhibitorscyclic ether DGAT1 inhibitors
- Patent number 9,108,956
- Issue date Aug 18, 2015
- Novartis AG
- Sejal Patel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic bridgehead ether DGAT1 inhibitors
- Patent number 8,993,619
- Issue date Mar 31, 2015
- Novartis AG
- Sejal Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20240140959
- Publication date May 2, 2024
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTI...
- Publication number 20240043425
- Publication date Feb 8, 2024
- Novartis AG
- Mallesh BUSHABOINA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20230212139
- Publication date Jul 6, 2023
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20220411435
- Publication date Dec 29, 2022
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRD9 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE
- Publication number 20220315578
- Publication date Oct 6, 2022
- Novartis AG
- Xin CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTI...
- Publication number 20220048909
- Publication date Feb 17, 2022
- Novartis AG
- Mallesh BUSHABOINA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20210130365
- Publication date May 6, 2021
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20210107889
- Publication date Apr 15, 2021
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS
- Publication number 20150166563
- Publication date Jun 18, 2015
- Novartis AG
- Sejal Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLIC ETHER DGAT1 INHIBITORSCYCLIC ETHER DGAT1 INHIBITORS
- Publication number 20150141474
- Publication date May 21, 2015
- Novartis AG
- Sejal Patel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS
- Publication number 20130289058
- Publication date Oct 31, 2013
- Sejal Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Heteroaryl substituted spiropiperidinyl derivatives and pharmaceuti...

2-azaspiro[3.4]octane derivatives as M4 agonists

2-azaspiro[3.4]octane derivatives as M4 agonists

Heteroaryl substituted spiropiperidinyl derivatives and pharmaceuti...

2-azaspiro[3.4]octane derivatives as M4 agonists

2-azaspiro[3.4]octane derivatives as M4 agonists

Cyclic ether DGAT1 inhibitorscyclic ether DGAT1 inhibitors

Cyclic bridgehead ether DGAT1 inhibitors

Patents Applicationslast 30 patents

2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS

HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTI...

2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS

2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS

BRD9 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE

HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTI...

2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS

2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS

CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS

CYCLIC ETHER DGAT1 INHIBITORSCYCLIC ETHER DGAT1 INHIBITORS

CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS